Insider Trading Alert - NLSN, CFFN And CLB Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, Feb. 3, 2015, 67 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $604.38 to $199,999,963.35.

Highlighted Stocks Traded by Insiders:

Nielsen (NLSN) - FREE Research Report

Valcon Acquisition Holding (Luxembourg) S.A R.L., who is 10% Owner at Nielsen, sold 4.5 million shares at $43.97 on Feb. 3, 2015. Following this transaction, the 10% Owner owned 47.0 million shares meaning that the stake was reduced by 8.83% with the 4.5 million-share transaction.

The shares most recently traded at $44.12, up $0.15, or 0.34% since the insider transaction. Historical insider transactions for Nielsen go as follows:

  • 4-Week # shares sold: 2.6 million
  • 12-Week # shares sold: 22.6 million
  • 24-Week # shares sold: 22.7 million

The average volume for Nielsen has been 3.2 million shares per day over the past 30 days. Nielsen has a market cap of $16.7 billion and is part of the technology sector and computer software & services industry. Shares are down 1.3% year-to-date as of the close of trading on Tuesday.

Nielsen N.V. provides media and marketing information, analytics, and industry expertise about what consumers watch and listen. The company operates in two segments, Buy and Watch. The stock currently has a dividend yield of 2.29%. The company has a P/E ratio of 44.2. Currently, there are 12 analysts who rate Nielsen a buy, 1 analyst rates it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on NLSN - FREE

TheStreet Quant Ratings rates Nielsen as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, good cash flow from operations, expanding profit margins, increase in stock price during the past year and notable return on equity. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Nielsen Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Capitol Federal Financial (CFFN) - FREE Research Report

Morris James G., who is Director at Capitol Federal Financial, bought 3,000 shares at $12.44 on Feb. 3, 2015. Following this transaction, the Director owned 17,790 shares meaning that the stake was boosted by 20.28% with the 3,000-share transaction.

The shares most recently traded at $12.68, up $0.24, or 1.89% since the insider transaction. Historical insider transactions for Capitol Federal Financial go as follows:

  • 4-Week # shares bought: 3,000
  • 12-Week # shares bought: 3,000
  • 24-Week # shares bought: 3,000
  • 24-Week # shares sold: 2,000

The average volume for Capitol Federal Financial has been 531,900 shares per day over the past 30 days. Capitol Federal Financial has a market cap of $1.8 billion and is part of the financial sector and banking industry. Shares are down 2.19% year-to-date as of the close of trading on Tuesday.

Capitol Federal Financial, Inc. operates as the holding company for Capitol Federal Savings Bank that provides a range of retail banking products and services in the United States. The stock currently has a dividend yield of 2.72%. The company has a P/E ratio of 22.3. Currently, there are no analysts who rate Capitol Federal Financial a buy, no analysts rate it a sell, and 3 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on CFFN - FREE

TheStreet Quant Ratings rates Capitol Federal Financial as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, impressive record of earnings per share growth, increase in net income, expanding profit margins and reasonable valuation levels. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook. Get the full Capitol Federal Financial Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Core Laboratories (CLB) - FREE Research Report

Van Kempen Margaret Ann, who is Director at Core Laboratories, bought 250 shares at $102.07 on Feb. 3, 2015. Following this transaction, the Director owned 350 shares meaning that the stake was boosted by 250% with the 250-share transaction.

The shares most recently traded at $107.00, up $4.93, or 4.6% since the insider transaction. Historical insider transactions for Core Laboratories go as follows:

  • 4-Week # shares bought: 300
  • 4-Week # shares sold: 1,000
  • 12-Week # shares bought: 395
  • 12-Week # shares sold: 1,000
  • 24-Week # shares bought: 395
  • 24-Week # shares sold: 1,000

The average volume for Core Laboratories has been 891,200 shares per day over the past 30 days. Core Laboratories has a market cap of $4.3 billion and is part of the basic materials sector and energy industry. Shares are down 12.22% year-to-date as of the close of trading on Tuesday.

Core Laboratories N.V. provides reservoir description, production enhancement, and reservoir management services to the oil and gas industry in the Netherlands and internationally. The company operates in three segments: Reservoir Description, Production Enhancement, and Reservoir Management. The stock currently has a dividend yield of 2.25%. The company has a P/E ratio of 16.7. Currently, there are 4 analysts who rate Core Laboratories a buy, no analysts rate it a sell, and 5 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on CLB - FREE

TheStreet Quant Ratings rates Core Laboratories as a hold. The company's strengths can be seen in multiple areas, such as its increase in net income, revenue growth and notable return on equity. However, as a counter to these strengths, we also find weaknesses including a generally disappointing performance in the stock itself and generally higher debt management risk. Get the full Core Laboratories Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

null

More from Markets

Inside Carnival's Mind Blowing New Horizon Cruise Ship (Video)

Inside Carnival's Mind Blowing New Horizon Cruise Ship (Video)

Jim Cramer: The 10-Year Yield Could Go to 2.75%

Jim Cramer: The 10-Year Yield Could Go to 2.75%

Oil Slumps, Gas Spikes Ahead of Holiday Weekend; Assessing the Chipmakers--ICYMI

Oil Slumps, Gas Spikes Ahead of Holiday Weekend; Assessing the Chipmakers--ICYMI

Week Ahead: Wall Street Looks to Jobs Report as North Korea Meeting Less Certain

Week Ahead: Wall Street Looks to Jobs Report as North Korea Meeting Less Certain

Dow and S&P 500 Decline, Energy Shares Fall as U.S. Crude Oil Slides 4%

Dow and S&P 500 Decline, Energy Shares Fall as U.S. Crude Oil Slides 4%